Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AMYOTROPHIC LATERAL SCLEROSIS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05568615
What this trial is testing

Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALS

Who this might be right for
ALS
Shionogi 15
Early research (Phase 1)Study completedNCT03520517
What this trial is testing

Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS

Who this might be right for
Amyotrophic Lateral SclerosisALSLou Gehrig Disease+3 more
Biohaven Pharmaceuticals, Inc. 22
Not applicableLooking for participantsNCT07187388
What this trial is testing

Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Primary Lateral Sclerosis (PLS)Motor Neuron Disease, Amyotrophic Lateral Sclerosis
Nova Southeastern University 10
Not applicableUnknownNCT06539169
What this trial is testing

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Who this might be right for
Alpha-ThalassemiaBeta-ThalassemiaAmyloidosis+14 more
xCures 1,000
Testing effectiveness (Phase 2)Temporarily pausedNCT03755167
What this trial is testing

A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IV

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Immunity Pharma Ltd. 15
Not applicableLooking for participantsNCT03225144
What this trial is testing

Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Who this might be right for
Frontotemporal DementiaAmyotrophic Lateral SclerosisProgressive Supranuclear Palsy
National Institute of Neurological Disorders and Stroke (NINDS) 360
Testing effectiveness (Phase 2)UnknownNCT03136809
What this trial is testing

ALS Treatment Extension Study

Who this might be right for
Amyotrophic Lateral Sclerosis
Collaborative Medicinal Development Pty Limited 28
Early research (Phase 1)UnknownNCT06181526
What this trial is testing

Safety and Preliminary Efficacy of Aleeto in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Beijing Tiantan Hospital 24
Not applicableUnknownNCT02665663
What this trial is testing

Tongue Strength in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Assistance Publique Hopitaux De Marseille 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05299658
What this trial is testing

An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic Catalysis With CNM-Au8 to Slow Disease Progression in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Clene Nanomedicine 40
Testing effectiveness (Phase 2)Study completedNCT03506425
What this trial is testing

A Pilot Trial of Triheptanoin for People With Amyotrophic Lateral Sclerosis (PALS)

Who this might be right for
ALS
Richard Bedlack, M.D., Ph.D. 15
Testing effectiveness (Phase 2)Looking for participantsNCT07142291
What this trial is testing

PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
PhenoNet, Inc. 105
Not applicableStudy completedNCT01874808
What this trial is testing

From Movement Preparation to Gait Execution in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Institut National de la Santé Et de la Recherche Médicale, France 59
Early research (Phase 1)Study completedNCT01424176
What this trial is testing

Dexpramipexole Renal PK Study

Who this might be right for
Amyotrophic Lateral SclerosisRenal Insufficiency
Knopp Biosciences 36
Not applicableStudy completedNCT02574390
What this trial is testing

Answer ALS: Individualized Initiative for ALS Discovery

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisFlail Arm ALS+5 more
Johns Hopkins University 1,049
Testing effectiveness (Phase 2)Active Not RecruitingNCT06977451
What this trial is testing

Personalized Antisense Oligonucleotide for a Single Participant With CHCHD10 ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
n-Lorem Foundation 1
Not applicableUnknownNCT06320444
What this trial is testing

Non-invasive Spinal, Cortical, and Sensorimotor Biomarkers in Motor Neurone Disease

Who this might be right for
Motor Neuron Disease, Amyotrophic Lateral SclerosisMotor Neuron Disease Progressive Spinal Muscle AtrophyPrimary Lateral Sclerosis+2 more
University of Dublin, Trinity College 240
Testing effectiveness (Phase 2)Study completedNCT00244244
What this trial is testing

A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
CytRx 80
Not applicableWithdrawnNCT03034317
What this trial is testing

NeuRx Diaphram Pacing System (DPS) Use in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Synapse Biomedical
Testing effectiveness (Phase 2)Study completedNCT00409721
What this trial is testing

The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Alberta 42
Next Page